- Home
- GEVO vs ABSI Comparison
GEVO vs ABSI Comparison
Compare GEVO & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GEVO
- ABSI
- Stock Information
- Founded
- GEVO 2005
- ABSI 2011
- Country
- GEVO United States
- ABSI United States
- Employees
- GEVO N/A
- ABSI N/A
- Industry
- GEVO Major Chemicals
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- GEVO Industrials
- ABSI Health Care
- Exchange
- GEVO Nasdaq
- ABSI Nasdaq
- Market Cap
- GEVO 285.1M
- ABSI 353.8M
- IPO Year
- GEVO 2011
- ABSI 2021
- Fundamental
- Price
- GEVO $1.14
- ABSI $2.80
- Analyst Decision
- GEVO Buy
- ABSI Strong Buy
- Analyst Count
- GEVO 2
- ABSI 5
- Target Price
- GEVO $7.58
- ABSI $8.40
- AVG Volume (30 Days)
- GEVO 2.4M
- ABSI 2.5M
- Earning Date
- GEVO 05-13-2025
- ABSI 05-13-2025
- Dividend Yield
- GEVO N/A
- ABSI N/A
- EPS Growth
- GEVO N/A
- ABSI N/A
- EPS
- GEVO N/A
- ABSI N/A
- Revenue
- GEVO $16,915,000.00
- ABSI $4,534,000.00
- Revenue This Year
- GEVO $617.82
- ABSI $158.58
- Revenue Next Year
- GEVO $84.22
- ABSI $93.12
- P/E Ratio
- GEVO N/A
- ABSI N/A
- Revenue Growth
- GEVO N/A
- ABSI N/A
- 52 Week Low
- GEVO $0.48
- ABSI $2.01
- 52 Week High
- GEVO $3.39
- ABSI $6.33
- Technical
- Relative Strength Index (RSI)
- GEVO 49.70
- ABSI 44.49
- Support Level
- GEVO $1.00
- ABSI $2.85
- Resistance Level
- GEVO $1.14
- ABSI $3.16
- Average True Range (ATR)
- GEVO 0.08
- ABSI 0.20
- MACD
- GEVO 0.00
- ABSI -0.03
- Stochastic Oscillator
- GEVO 60.87
- ABSI 19.57
About GEVO Gevo Inc.
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.